PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-25
DOI
10.3389/fonc.2020.614365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nucleic Acid–Based Therapeutics for Parkinson’s Disease
- (2019) Masayuki Nakamori et al. Neurotherapeutics
- Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
- (2019) Xiaoyun Li et al. Nature Reviews Clinical Oncology
- RNAi therapeutic and its innovative biotechnological evolution
- (2019) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- Development of the Inhibitors that Target the PD-1/PD-L1 Interaction—A Brief Look at Progress on Small Molecules, Peptides and Macrocycles
- (2019) Guzik et al. MOLECULES
- PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
- (2019) Yilun Wu et al. Frontiers in Immunology
- Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine
- (2019) Hadi Hassannia et al. IMMUNOLOGY
- Stimuli‐responsive nanoparticles for the codelivery of chemotherapeutic agents doxorubicin and siPD‐L1 to enhance the antitumor effect
- (2019) Ye‐juan Zhou et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth
- (2019) Seo Young Kwak et al. MOLECULAR PHARMACEUTICS
- Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine
- (2019) Zhihang Chen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
- (2018) Tina Cascone et al. Cell Metabolism
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation
- (2018) Yi Zhang et al. Oncology Letters
- Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation
- (2018) Zhihang Chen et al. Theranostics
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1/PD-L1 and Other Emerging Checkpoint Pathways
- (2018) Pottayil G. Sasikumar et al. BIODRUGS
- RNA Therapeutics in Cardiovascular Precision Medicine
- (2018) Ageliki Laina et al. Frontiers in Physiology
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion
- (2018) Xichun Xia et al. Frontiers in Oncology
- Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
- (2017) Martin Rao et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis
- (2017) Ya-Mei Hu et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells
- (2017) J Feng et al. ONCOGENE
- PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration
- (2017) Elena Brin et al. Oncotarget
- Advances in siRNA delivery in cancer therapy
- (2017) Aishwarya Singh et al. Artificial Cells Nanomedicine and Biotechnology
- Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
- (2017) Seema Gupta et al. Frontiers in Oncology
- Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
- (2016) Curtis A. Clark et al. CANCER RESEARCH
- Management of toxicities of immune checkpoint inhibitors
- (2016) Lavinia Spain et al. CANCER TREATMENT REVIEWS
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery
- (2016) Xiao Tong et al. Theranostics
- Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy
- (2016) Zhihang Chen et al. Nanomaterials
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
- (2015) Sonja Kleffel et al. CELL
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Recent advances in curcumin nanoformulation for cancer therapy
- (2014) Wing-Hin Lee et al. Expert Opinion on Drug Delivery
- Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
- (2013) Z. Husain et al. JOURNAL OF IMMUNOLOGY
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: a comparison of ectopic and orthotopic tumours
- (2012) Karyn S Ho et al. BMC CANCER
- Nanoplex Delivery of siRNA and Prodrug Enzyme for Multimodality Image-Guided Molecular Pathway Targeted Cancer Therapy
- (2010) Cong Li et al. ACS Nano
- Acetal Linked Oligoethylenimines for Use As pH-Sensitive Gene Carriers
- (2008) Veronika Knorr et al. BIOCONJUGATE CHEMISTRY
- Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
- (2008) Michelle Longmire et al. Nanomedicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now